PEDIATRICS Vol. 55 No. 2 February 1975, pp. 299-300
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleisher, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fleisher, D. R.

Lettrt To The Editor

David R. Fleisher M.D.1

1 9735 Wilshire Boulevard Beverly Hills, California 90212

I would state that in the past six years, during which my practice has been confined to pediatric gastroenterology, I have not had the opportunity to treat a single patient with acrodermatitis enteropathica. I agree that the halogenated hydroxyquinolines are the drug of choice for this condition. It may be of interest that approximately 15% of all my new referrals are infants or school-age children with irritable colon syndrome as described by Murray Davidson and others.